OBJECTIVE: The purpose of this study was to determine the usefulness of a simple screening tool for bleeding disorders in a multisite population of women with menorrhagia. STUDY DESIGN: Women with menorrhagia between the ages of 18 and 50 years from 6 geographically diverse US centers underwent hemostatic testing for bleeding disorders, complete blood cell count, and ferritin. A questionnaire that contained all elements of the 8-question screening tool was administered. Sensitivity of the screening tool, a screening tool with a pictorial blood assessment chart (PBAC) score of >185, and a screening tool with serum ferritin were calculated for hemostatic disorders. RESULTS: Two hundred and seventeen women who were identified with a PBAC score of ≥100 participated in the study. The sensitivity of the screening tool was 89% for hemostatic defects, and sensitivity increased to 93% and 95% with a serum ferritin level of ≤20 ng/mL and a PBAC score of >185, respectively. CONCLUSION: This study confirms the usefulness of a short screening tool for the stratification of women with menorrhagia for hemostatic evaluation.
OBJECTIVE: The purpose of this study was to determine the usefulness of a simple screening tool for bleeding disorders in a multisite population of women with menorrhagia. STUDY DESIGN:Women with menorrhagia between the ages of 18 and 50 years from 6 geographically diverse US centers underwent hemostatic testing for bleeding disorders, complete blood cell count, and ferritin. A questionnaire that contained all elements of the 8-question screening tool was administered. Sensitivity of the screening tool, a screening tool with a pictorial blood assessment chart (PBAC) score of >185, and a screening tool with serum ferritin were calculated for hemostatic disorders. RESULTS: Two hundred and seventeen women who were identified with a PBAC score of ≥100 participated in the study. The sensitivity of the screening tool was 89% for hemostatic defects, and sensitivity increased to 93% and 95% with a serum ferritin level of ≤20 ng/mL and a PBAC score of >185, respectively. CONCLUSION: This study confirms the usefulness of a short screening tool for the stratification of women with menorrhagia for hemostatic evaluation.
Authors: Anne Dilley; Carolyn Drews; Cathy Lally; Harland Austin; Elizabeth Barnhart; Bruce Evatt Journal: J Womens Health Gend Based Med Date: 2002 Jan-Feb
Authors: C S Philipp; A Dilley; C H Miller; B Evatt; A Baranwal; R Schwartz; G Bachmann; P Saidi Journal: J Thromb Haemost Date: 2003-03 Impact factor: 5.824
Authors: Pamela E Warner; Hilary O D Critchley; Mary Ann Lumsden; Mary Campbell-Brown; Anne Douglas; Gordon D Murray Journal: Am J Obstet Gynecol Date: 2004-05 Impact factor: 8.661
Authors: E Berntorp; B Fuchs; M Makris; R Montgomery; V Flood; J S O'Donnell; A B Federici; D Lillicrap; P James; U Budde; M Morfini; P Petrini; S Austin; C Kannicht; V Jiménez-Yuste; C Lee Journal: Haemophilia Date: 2013-03 Impact factor: 4.287
Authors: Gillian C Lowe; Roksana Fickowska; Rashid Al Ghaithi; Annabel Maclachlan; Paul Harrison; Will Lester; Steve P Watson; Bethan Myers; Justin Clark; Neil V Morgan Journal: Platelets Date: 2018-12-06 Impact factor: 3.862